Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, January 25, 2024
Sterling Pharma Solutions, a global contract development and manufacturing organization, announced the results of a pilot project to assess the use of new, ultra-low charge ammonia chilling technology.
read more
Tuesday, October 08, 2024
Sterling Pharma Solutions, a contract development and manufacturing organization, and Soligenix, a late-stage biopharmaceutical company focused on developing and commercialization of products to treat rare diseases where there is an unmet medical ...
read more
Wednesday, October 12, 2016
UK-based Sterling Pharma Solutions has formed as an independent contract development and manufacturing organisation (CDMO) following a management buyout (MBO) of the UK based Dudley site.
read more
Sterling Pharma Solutions, is investing $1.5 million into a phased expansion of its US facility in North Carolina.
read more
Wednesday, April 19, 2023
Sterling Pharma Solutions announced it has been granted Manufacturer’s Authorization for Investigational Medicinal Products from the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA).
read more
Tuesday, January 25, 2022
The project will include the construction of five new laboratories: two of which will be dedicated to research and development; a scale-up chemical synthesis laboratory; as well as Quality Control and analytical services laboratories. All work is due...
read more
Wednesday, January 24, 2018
API developer and manufacturer, Sterling Pharma Solutions, announced it is expanding its capacity in Japan.
read more
Sterling Pharma Solutions, a global contract development and manufacturing organization, announced a $3 million investment at its Germantown, WI facility, to expand its integrated antibody-drug conjugate (ADC) development and manufacturing ...
read more
Wednesday, March 02, 2022
Sterling Pharma Solutions has reached an agreement with Novartis to acquire its Ringaskiddy campus (Novartis Ringaskiddy Limited), near Cork, Ireland. Financial details of the sale, which is expected to close in Q4, 2022, have not been disclosed.
read more
Sterling Pharma Solutions announced that it has expanded its bioanalytical services offering at its Deeside, UK site, which is the company’s dedicated facility for antibody-drug conjugates (ADCs).
read more
Thursday, October 31, 2024
Sterling Pharma Solutions announced the second phase of an expansion strategy at its Deeside, UK site to support antibody-drug conjugate (ADC) development, with a more than £10 million investment to increase GMP bioconjugation capacity.
read more
Tuesday, January 10, 2023
Sterling Pharma Solutions announced the completion of its acquisition of an active pharmaceutical ingredient (API) manufacturing facility in Ringaskiddy, Ireland, from Novartis, in a deal that was initially announced in March 2022.
read more
Sterling Pharma Solutions has commenced production of hydroxychloroquine (HCQ), a treatment currently under investigation for COVID-19.
read more
Wednesday, September 08, 2021
Sterling Pharma Solutions, a global contract development and manufacturing organisation, today announced that it has been awarded a gold medal by EcoVadis, in recognition of the company’s sustainability management system through its policies, actions...
read more
Sterling Pharma Solutions, a global contract development and manufacturing organisation, announced the appointment of Stewart Mitchell as site head of its new antibody-drug conjugate (ADC) facility in Deeside, UK. Dr Mitchell brings more than 25 ...
read more